These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 24503616

  • 1. Novel tubulin and tau neuroprotective fragments sharing structural similarities with the drug candidate NAP (Davuentide).
    Gozes I, Iram T, Maryanovsky E, Arviv C, Rozenberg L, Schirer Y, Giladi E, Furman-Assaf S.
    J Alzheimers Dis; 2014; 40 Suppl 1():S23-36. PubMed ID: 24503616
    [Abstract] [Full Text] [Related]

  • 2. NAP alpha-aminoisobutyric acid (IsoNAP).
    Gozes I, Schirer Y, Idan-Feldman A, David M, Furman-Assaf S.
    J Mol Neurosci; 2014 Jan; 52(1):1-9. PubMed ID: 24458740
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP).
    Magen I, Gozes I.
    Neuropeptides; 2013 Dec; 47(6):489-95. PubMed ID: 24210139
    [Abstract] [Full Text] [Related]

  • 5. The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protection.
    Gozes I, Divinski I.
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S37-41. PubMed ID: 15665412
    [Abstract] [Full Text] [Related]

  • 6. NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.
    Shiryaev N, Jouroukhin Y, Giladi E, Polyzoidou E, Grigoriadis NC, Rosenmann H, Gozes I.
    Neurobiol Dis; 2009 May; 34(2):381-8. PubMed ID: 19264130
    [Abstract] [Full Text] [Related]

  • 7. Peptide neuroprotection through specific interaction with brain tubulin.
    Divinski I, Holtser-Cochav M, Vulih-Schultzman I, Steingart RA, Gozes I.
    J Neurochem; 2006 Aug; 98(3):973-84. PubMed ID: 16893427
    [Abstract] [Full Text] [Related]

  • 8. D-NAP prophylactic treatment in the SOD mutant mouse model of amyotrophic lateral sclerosis: review of discovery and treatment of tauopathy.
    Jouroukhin Y, Ostritsky R, Gozes I.
    J Mol Neurosci; 2012 Nov; 48(3):597-602. PubMed ID: 22956189
    [Abstract] [Full Text] [Related]

  • 9. NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42).
    Gozes I, Divinski I, Piltzer I.
    BMC Neurosci; 2008 Dec 10; 9 Suppl 3(Suppl 3):S3. PubMed ID: 19091000
    [Abstract] [Full Text] [Related]

  • 10. Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model.
    Vulih-Shultzman I, Pinhasov A, Mandel S, Grigoriadis N, Touloumi O, Pittel Z, Gozes I.
    J Pharmacol Exp Ther; 2007 Nov 10; 323(2):438-49. PubMed ID: 17720885
    [Abstract] [Full Text] [Related]

  • 11. The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activities.
    Oz S, Ivashko-Pachima Y, Gozes I.
    PLoS One; 2012 Nov 10; 7(12):e51458. PubMed ID: 23272107
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy.
    Ivashko-Pachima Y, Sayas CL, Malishkevich A, Gozes I.
    Mol Psychiatry; 2017 Sep 10; 22(9):1335-1344. PubMed ID: 28115743
    [Abstract] [Full Text] [Related]

  • 17. Microtubules, schizophrenia and cognitive behavior: preclinical development of davunetide (NAP) as a peptide-drug candidate.
    Gozes I.
    Peptides; 2011 Feb 10; 32(2):428-31. PubMed ID: 21050875
    [Abstract] [Full Text] [Related]

  • 18. NAP (davunetide) provides functional and structural neuroprotection.
    Gozes I.
    Curr Pharm Des; 2011 Feb 10; 17(10):1040-4. PubMed ID: 21524250
    [Abstract] [Full Text] [Related]

  • 19. The microtubule interacting drug candidate NAP protects against kainic acid toxicity in a rat model of epilepsy.
    Zemlyak I, Manley N, Vulih-Shultzman I, Cutler AB, Graber K, Sapolsky RM, Gozes I.
    J Neurochem; 2009 Dec 10; 111(5):1252-63. PubMed ID: 19799711
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.